Analysis of expression and function of vacuolar-type H^+-ATPase at bladder

膀胱液泡型H^-ATP酶的表达及功能分析

基本信息

  • 批准号:
    08457424
  • 负责人:
  • 金额:
    $ 4.03万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

Vacuolar-type H^+-ATPases were present in luminal cytoplasmic membrane of bladder superficial cells in mammals including human ; which secrete protons to acidify the urine in the bladder. In order to study their expression process, we have developed an experimental model for regeneration of superficial cells of mouse bladder. In this model, the expression level of V-ATPase mRNA,which was measured by Northern blot hybridization using cDNA of V-ATPase proteolipid gene, increased significantly 3 hours after exfoliation of superficial cells by trypsin treatment. On the other hand, western blotting using three different cells fractions, superficial cells rich fraction, intermediate and basal cells rich fraction, and whole cells, revealed almost same levels of V-ATPase protein expression. These results suggested that V-ATPases present in endomembrane systems moved into luminal cytoplasmic membrane of bladder superficial cells during cell differentiation from intermediate to superficial cells. We also examined the role of V-ATPase in establishing mucosal barrier against infection as well as blood-urine barrier.
在包括人类在内的哺乳动物中,存在于膀胱表面细胞的管腔细胞质膜上,分泌质子使膀胱内的尿液酸化。为了研究它们的表达过程,我们建立了小鼠膀胱表面细胞再生的实验模型。在该模型中,用胰蛋白酶处理表皮细胞后3小时,用V-ATP酶蛋白脂基因的cDNA通过北方印迹杂交测量的V-ATP酶mRNA的表达水平显著增加。另一方面,使用三种不同的细胞级分,表层细胞丰富级分,中间和基底细胞丰富级分,和全细胞的蛋白质印迹,揭示了几乎相同的水平的V-ATP酶蛋白质的表达。这些结果表明,V-ATP酶存在于内膜系统的迁移到管腔细胞质膜的膀胱表浅细胞从中间到表浅细胞分化过程中。我们还研究了V-ATP酶在建立粘膜屏障和血-尿屏障中的作用。

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kumon, H.et al.: "Fully hydrated images of Pseudomonas aeruginosa biofilm on the surface of catheter material." Can.J.Urology. 4. 416-421 (1997)
Kumon, H.et al.:“导管材料表面铜绿假单胞菌生物膜的完全水合图像。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomochika, K., Shinoda, S., Kumon, H., MOri, M., Moriyama, Y., and Futai M.: "Vacuolar ATPase in mouse bladder epithelium is responsible for urinary acidification." FEBS Letters. 404. 61-64 (1997)
Tomochika, K.、Shinoda, S.、Kumon, H.、MOri, M.、Moriyama, Y. 和 Futai M.:“小鼠膀胱上皮细胞中的液泡 ATP 酶负责尿液酸化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kumon, H.: "Pathogenesis and management of bacterial biofilms in the urinary tract." J.Infect.Chemother.2. 18-28 (1996)
Kumon, H.:“泌尿道细菌生物膜的发病机制和管理。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., and Tashiro, Y.: "Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells." Cell Struc
Yamamoto, A.、Takawa, Y.、Yoshimori, T.、Moriyama, Y.、Masaki, R. 和 Tashiro, Y.:“Bafilomycin A1 通过抑制大鼠肝癌细胞中自噬体和溶酶体之间的融合来防止自噬液泡的成熟
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomochika, K.et al.: "Vacuolar ATPase in mouse bladder epithelium is responsible for urinary acidification." FEBS Letters. 404. 61-64 (1997)
Tomochika, K.等人:“小鼠膀胱上皮细胞中的液泡 ATP 酶负责尿液酸化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUMON Hiromi其他文献

KUMON Hiromi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUMON Hiromi', 18)}}的其他基金

Investigation of the mechanisms of personalized-cancer vaccination by REIC/Dkk-3 based gene therapy.
基于 REIC/Dkk-3 的基因治疗的个性化癌症疫苗接种机制的研究。
  • 批准号:
    23390382
  • 财政年份:
    2011
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel methods for identifying antibiofilm agents against multidrug-resistant Acinetobacter baumannii
开发鉴定针对多重耐药鲍曼不动杆菌的抗生物膜剂的新方法
  • 批准号:
    23659759
  • 财政年份:
    2011
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The molecular function of immortalization-related genes in the regulation of Oncogenic Ras and prostatic carcinogenesis.
永生化相关基因在致癌 Ras 和前列腺癌发生调控中的分子功能。
  • 批准号:
    20390426
  • 财政年份:
    2008
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
DEVELOPMENT OF TAILORED-MADE TYPE PROSTATE CANCER GENE THERAPY AIMING AT SYSTEMIC IMMUNE-ACTIVATION
开发针对全身免疫激活的定制型前列腺癌基因疗法
  • 批准号:
    15209052
  • 财政年份:
    2003
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of non invasive lower urinary tract function test using ultrasound Doppler imaging
超声多普勒成像无创下尿路功能测试的发展
  • 批准号:
    13557135
  • 财政年份:
    2001
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ENHANCEMENT OF BYSTANDER EFFECTS WITH THE COMBINATION OF IMMUNO-GENE THERAPY AND PRO-DRUG GENE THERAPY
免疫基因疗法和前药基因疗法相结合增强旁观者效应
  • 批准号:
    13671653
  • 财政年份:
    2001
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Role of Fimbriae of Escherichia coli in Genitourinary Tract Infection.
大肠杆菌菌毛在泌尿生殖道感染中的作用。
  • 批准号:
    02670708
  • 财政年份:
    1990
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Proton pump-initiated synthesis of a conductive polypyrrole for genetically targeted chemical assembly on living neurons
质子泵引发的导电聚吡咯合成,用于活体神经元上的基因靶向化学组装
  • 批准号:
    567675-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Reducing Gastrointestinal Bleeding with Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism (RADIANT) Pilot Randomized Trial
在急性静脉血栓栓塞中使用质子泵抑制剂治疗减少胃肠道出血 (RADIANT) 试点随机试验
  • 批准号:
    470380
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Operating Grants
Big data to inform the impact of antibiotics and proton pump inhibitors on immunotherapies used to treat lung cancer
大数据告知抗生素和质子泵抑制剂对肺癌免疫疗法的影响
  • 批准号:
    nhmrc : 2005294
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Postgraduate Scholarships
Mechanistic analysis of catalysis and regulation of the fungal proton pump Pma1
真菌质子泵Pma1催化与调控的机理分析
  • 批准号:
    BB/V007653/1
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Research Grant
Molecular mechanism underlying organelle trafficking regulated by stractually diverse proton pump vacolar ATPase
结构多样的质子泵空泡 ATP 酶调节细胞器运输的分子机制
  • 批准号:
    21H02627
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the activation mechanism of plasma membrane proton pump in stomatal opening
阐明气孔开放质膜质子泵的激活机制
  • 批准号:
    20K06703
  • 财政年份:
    2020
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis on the pathogenesis of proton pump inhibitor-associated fundic gland polyps and dysplasia
质子泵抑制剂相关性胃底腺息肉及不典型增生的发病机制分析
  • 批准号:
    20K16174
  • 财政年份:
    2020
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Does Cytochrome c Oxidase control proton-pump mechanism by small structural changes?
细胞色素 c 氧化酶是否通过微小的结构变化来控制质子泵机制?
  • 批准号:
    20K03794
  • 财政年份:
    2020
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Co-opting of a host proton pump for replication of plant RNA viruses
选择宿主质子泵来复制植物RNA病毒
  • 批准号:
    19K15841
  • 财政年份:
    2019
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Pragmatic Cluster, Randomized, Crossover, Registry-Embedded Clinical Trial of Proton Pump Inhibitors vs. Histamine-2 Receptor Blockers for Stress Ulcer Prophylaxis Therapy in the Intensive Care Unit (PEPTIC Study)
质子泵抑制剂与组胺 2 受体阻滞剂在重症监护病房进行应激性溃疡预防治疗的实用集群、随机、交叉、注册临床试验(PEPTIC 研究)
  • 批准号:
    380177
  • 财政年份:
    2018
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了